• Conference Proceeding

An Exploration of the Association of Quality-of-Life(QOL) Scores with Tumor Progression Status in First Line Hormone Receptor Positive, HER2+Metastatic Breast Cancer (MBC) Patients Treated with Lapatinib Plus Letrozole or Letrozole Alone

Citation

Sherrill, B., Amonkar, M. M., Sherif, B. N., Maltzman, J., O'Rourke, L., & Johnston, S. (2009). An Exploration of the Association of Quality-of-Life(QOL) Scores with Tumor Progression Status in First Line Hormone Receptor Positive, HER2+Metastatic Breast Cancer (MBC) Patients Treated with Lapatinib Plus Letrozole or Letrozole Alone. In [69], pp. 801S–801S. .

Abstract